Skip to main content
. 2020 Apr;61(4):512–519. doi: 10.2967/jnumed.119.229781

FIGURE 7.

FIGURE 7.

Whole-body (maximum-intensity projection) image (A), 89Zr-IAB22M2C (1.0 mg) images (B), and 18F-FDG images (C) of patient with lung cancer not initiated on immunotherapy. Lesions that are 18F-FDG–positive in left neck (SUVmax, 17.8; 3.2 cm), mediastinum (SUVmax, 11.1; 2.2 cm), left upper lobe (SUVmax, 20.4; 4.7 cm), and liver (SUVmax, 11.6; 3.7 cm) show no uptake of 89Zr-IAB22M2C.